
SYNNEX ($SNX) reported a strong Q2, with earnings of $2.99 per share and revenue of $14.95 billion, both significantly exceeding analyst estimates. Despite this robust financial performance, the company has experienced substantial insider selling over the past six months, including 35 sales totaling millions from key executives and no purchases. Institutional investor activity remains mixed, with a near-even split between firms adding and reducing positions, while one analyst firm maintains an "Outperform" rating, presenting a nuanced outlook for the stock.
SYNNEX ($SNX) has presented a dichotomous investment profile, marked by strong operational performance juxtaposed with bearish insider sentiment. The company reported a significant quarterly beat, with earnings of $2.99 per share exceeding estimates by $0.23 and revenue of $14.95 billion surpassing forecasts by over $505 million. This robust financial result, however, is contrasted by a complete lack of insider buying over the last six months, a period which saw 35 open-market sales from key executives including the CEO, CFO, and other senior leaders, liquidating millions in stock. The institutional landscape reflects this uncertainty, with a nearly even split between firms increasing (256) and decreasing (261) their positions. While several large funds like Nuveen Asset Management and Boston Partners initiated or significantly added to their stakes, other major holders like Causeway Capital Management have drastically reduced their exposure by 78%. Analyst coverage cited is minimal but positive, with a single "Outperform" rating from RBC Capital, offering little to resolve the conflicting signals between the company's strong fundamentals and the actions of its most informed insiders.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment